Patterns of liver iron accumulation in patients with sickle cell disease and thalassemia with iron overload
- PMID: 20374273
- PMCID: PMC2989598
- DOI: 10.1111/j.1600-0609.2010.01449.x
Patterns of liver iron accumulation in patients with sickle cell disease and thalassemia with iron overload
Abstract
The rate and pattern of iron deposition and accumulation are important determinants of liver damage in chronically transfused patients. To investigate iron distribution patterns at various tissue iron concentrations, effects of chelation on hepatic iron compartmentalization, and differences between patients with sickle cell disease (SCD) and thalassemia major (TM), we prospectively investigated hepatic histologic and biochemical findings in 44 patients with iron overload (35 SCD and 9 TM). The median hepatic iron content (HIC) in patients with TM and SCD was similar at 12.9 and 10.3 mg Fe/g dry weight, respectively (P = 0.73), but patients with SCD had significantly less hepatic fibrosis and inflammation (P < 0.05), less hepatic injury, and significantly less blood exposure. Patients with SCD had predominantly sinusoidal iron deposition, but hepatocyte iron deposition was observed even at low HIC. Chelated patients had more hepatocyte and portal tract iron than non-chelated ones, but similar sinusoidal iron deposition. These data suggest that iron deposition in patients with SCD generally follows the traditional pattern of transfusional iron overload; however, parenchymal hepatocyte deposition also occurs early and chelation removes iron preferentially from the reticuloendothelium. Pathophysiological and genetic differences affecting iron deposition and accumulation in SCD and TM warrants further investigation.
Trial registration: ClinicalTrials.gov NCT00675038.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures


Similar articles
-
Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.J Pediatr Hematol Oncol. 2009 May;31(5):309-12. doi: 10.1097/MPH.0b013e3181a1c143. J Pediatr Hematol Oncol. 2009. PMID: 19415007
-
Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.Br J Haematol. 2016 Nov;175(4):705-713. doi: 10.1111/bjh.14277. Epub 2016 Aug 10. Br J Haematol. 2016. PMID: 27507431
-
Patterns of hepatic iron distribution in patients with chronically transfused thalassemia and sickle cell disease.Am J Hematol. 2009 Aug;84(8):480-3. doi: 10.1002/ajh.21456. Am J Hematol. 2009. PMID: 19536851 Free PMC article.
-
Pathophysiology of transfusional iron overload: contrasting patterns in thalassemia major and sickle cell disease.Hemoglobin. 2009;33 Suppl 1:S37-45. doi: 10.3109/03630260903346627. Hemoglobin. 2009. PMID: 20001631 Review.
-
Consequences and management of iron overload in sickle cell disease.Hematology Am Soc Hematol Educ Program. 2013;2013:447-56. doi: 10.1182/asheducation-2013.1.447. Hematology Am Soc Hematol Educ Program. 2013. PMID: 24319218 Review.
Cited by
-
Iron as a therapeutic target in chronic liver disease.World J Gastroenterol. 2023 Jan 28;29(4):616-655. doi: 10.3748/wjg.v29.i4.616. World J Gastroenterol. 2023. PMID: 36742167 Free PMC article. Review.
-
Hepatic manifestations in hematological disorders.Int J Hepatol. 2013;2013:484903. doi: 10.1155/2013/484903. Epub 2013 Mar 31. Int J Hepatol. 2013. PMID: 23606974 Free PMC article.
-
Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.ScientificWorldJournal. 2012;2012:949535. doi: 10.1100/2012/949535. Epub 2012 Aug 1. ScientificWorldJournal. 2012. PMID: 22924029 Free PMC article. Review.
-
End-organ damage due to iron overload related to blood transfusion in an 11-year-old male.Ann Med Surg (Lond). 2023 Nov 27;86(1):575-579. doi: 10.1097/MS9.0000000000001555. eCollection 2024 Jan. Ann Med Surg (Lond). 2023. PMID: 38222744 Free PMC article.
-
Correlation of Transfusion Dependence and Its Associated Sequelae to Hematological and Biochemical Parameters in Patients With Sickle Cell Disease and Beta Thalassemia Major in Khobar: A Retrospective Study.Cureus. 2023 Jul 19;15(7):e42151. doi: 10.7759/cureus.42151. eCollection 2023 Jul. Cureus. 2023. PMID: 37602131 Free PMC article.
References
-
- Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339:5–11. - PubMed
-
- Adams RJ, Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med. 2005;353:2769–2778. - PubMed
-
- McCarville MB, Goodin GS, Fortner G, Li CS, Smeltzer MP, Adams R, Wang W. Evaluation of a comprehensive transcranial doppler screening program for children with sickle cell anemia. Pediatr Blood Cancer. 2008;50:818–821. - PubMed
-
- Piperno A. Classification and diagnosis of iron overload. Haematologica. 1998;83:447–455. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical